Back to Search
KAYLA ANTHONY, PHARMD
PHARMD
Pharmacist
NPI: 1528606969Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Inferiority of IL-2 alone versus IL-2 with HAART in maintaining CD4 T cell counts during HAART interruption: a randomized controlled trial.
PMID 19098490·AIDS·2009
3-trial
Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing.
PMID 19498037·Hum Mol Genet·2009
7-preclinical
A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells.
PMID 18996430·Vaccine·2009
7-preclinical
Correction for the effect of rising plasma glucose levels on quantification of MR(glc) with FDG-PET.
PMID 19293824·J Cereb Blood Flow Metab·2009
8-other
Effective siRNA targeting of the 3' untranslated region of the West Nile virus genome.
PMID 19135091·Antiviral Res·2009
7-preclinical
Invasive pneumococcal disease in Western Australia: emergence of serotype 19A.
PMID 19203324·Med J Aust·2009
8-other
Crystal structure of dengue virus type 1 envelope protein in the postfusion conformation and its implications for membrane fusion.
PMID 19244332·J Virol·2009
7-preclinical
Fusion loop peptide of the West Nile virus envelope protein is essential for pathogenesis and is recognized by a therapeutic cross-reactive human monoclonal antibody.
PMID 19535627·J Immunol·2009
7-preclinical
Interactions between morphological and physiological plasticity optimize energy acquisition in corals.
PMID 18481538·Ecology·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2750 W NEW HAVEN AVE, T-0689
MELBOURNE, FL 32904 - Phone
- (321) 722-9262
Quick Facts
- NPI
- 1528606969
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile